Fibrose Pulmonar Online (Pulmonary fibrosis)

■ The diagnosis of idiopathic pulmonary fibrosis: current and future approaches

Fernando J Martinez, Alison Chisholm, Harold R Collard et al

Lancet Respir Med. 2017, vol 5(1): 61–71

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524148/

■ Idiopathic pulmonary fibrosis in Switzerlands: diagnosis and treatment

Position paper of the Swiss Working Group for Interstitial and Rare Lung Diseases of the Swiss Respiratory Society

M Funke-Chambour, A Azzola, D Adler et al

Respiration 2017, vol 93: 363-378

https://www.karger.com/Article/Fulltext/464332

■ Oxigenoterapia de alto fluxo nasal em pacientes com fibrose pulmonary idiopática sob cuidados paliativos: relato de um caso

F S L Silva, P H Barreto, R S de Vasconcelos et al

Rev Med UFC 2017, vol 57 (1): 69-72

http://www.revistademedicina.ufc.br/ojs/index.php/revistademedicinaufc/article/view/174/135

■ Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen

Elisabeth Dowling Root, Bridget Graney, Susan Baird et al

BMC Pulm Med. 2017; vol 17: 154

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701349/

■ Recents advances in managing idiopathic pulmonary fibrosis

C Scelfo, A Caminati, S Harari

Version 1, F1000Res 2017, vol 6: 2052

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710314/

■ Fibrose pulmonar idiopática no Brasil: desafios para caracterização epidemiológica e abordagem

B G Baldi

bras. pneumol., Dec 2017, vol.43, no.6

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132017000600401&lng=pt&nrm=iso&tlng=pt

■ Mortalidade por fibrose pulmonar idiopática: análise temporal no Brasil, 1979-2014

Algranti, Eduardo et al

bras. pneumol., Dec 2017, vol.43, no.6, p.445-450

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132017000600445&lng=pt&nrm=iso&tlng=pt

■ Caracterización clínica, serológica y patrón radiológico de una cohorte unicéntrica de pacientes con enfermedad pulmonar difusa

Chahuán S, José Miguel et al

Rev. chil. enferm. respir., Mar 2017, vol.33, no.1, p.31-36.

https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-73482017000100005&lng=es&nrm=iso

■ Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis

L H Lancaster, J A de Andrade, J D Zibrak et al

European Respiratory Review 26 (146): 170057

http://err.ersjournals.com/content/26/146/170057

■ Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential

G Raghu

European Respiratory Review 26 (145): 170071

http://err.ersjournals.com/content/26/145/170071

■ Severe idiopathic pulmonary fibrosis: What can be done?

A Camininati, R Cassandro, Olga Torre, S Harari

European Respiratory Review 26 (145): 170004

http://err.ersjournals.com/content/26/145/170047

■ When to start and when to stop antifibrotic therapies

S E Torrisi, M Pavone, A Vancheri, C Vancheri

European Respiratory Review 26 (145): 170053

http://err.ersjournals.com/content/26/145/170053

■ Recent lessons learned in the management of acute exacerbations of idiopathic pulmonary fibrosis

Y Kondoh, V Cottin, K K Brown

European Respiratory Review 26 (145): 170050

http://err.ersjournals.com/content/26/145/170050

■ Overview of idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines

R Sharif

AJMC july 2017

http://www.ajmc.com/journals/supplement/2017/a-managed-care-perspective-treatment-of-idiopathic-pulmonary-fibrosis/overview-of-idiopathic-pulmonary-fibrosis-ipf-and-evidence-based-guidelines-article

■ Tracking dyspnea up to supplemental oxygen prescription among patients with pulmonary fibrosis

Amy L. Olson, Bridget Graney, Susan Baird et al

BMC Pulm Med. 2017; 17: 152

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700736/

■ Idiopathic pulmonary fibrosis: a genetic disease that involves mucociliary dysfunction of the peripheral airways

Christopher M. Evans, Tasha E. Fingerlin et al

Physiol Rev. 2016 Oct; 96(4): 1567–159

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243224/

■ Comorbid conditions in idiopathic pulmonary fibrosis: recognition and management

Justin M. Oldham, Harold R. Collard

Front Med (Lausanne) 2017; vol 4: 12

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539138/

■ Role of microbial agents in pulmonary fibrosis

Ozioma S. Chioma, Wonder P. Drake

Yale J Biol Med. 2017, vol 90(2): 219–227

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482299/

■ Informal caregivers experience of supplemental oxygen in pulmonary fibrosis

Bridget A. Graney, Frederick S. Wamboldt, Susan Baird et al

Health Qual Life Outcomes. 2017; vol 15: 133

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494136/

■ Pulmonary hypertension associated with idiopathic pulmonary fibrosis: current and future perspectives

Scott D. Collum, Javier Amione-Guerra, Ana S. Cruz-Solbes et al

Can Respir J. 2017; 2017: 1430350

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327768/

■ The processes and mechanisms of cardiac and pulmonary fibrosis

Lucy A. Murtha, Michael J. Schuliga, Nishani S. Mabotuwana et al

Front Physiol. 2017; vol 8: 777

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643461/

■ Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study

Richard J Allen, Joanne Porte, Rebecca Braybrooke et al

Lancet Respir Med. 2017, vol 5(11): 869–880

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666208/

■ Genetics in idiopathic pulmonary fibrosis pathogenesis, prognosis and treatment

Amarpreet Kaur, Susan K. Mathai, David A. Schwartz

Front Med (Lausanne) 2017; vol 4: 154

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622313/

■ Pulmonary fibrosis: tissue characterization using late-enhanced MRI compared with unenhanced anatomic high-resolution CT

Lisa P. Lavelle, Darragh Brady, Sinead McEvoy et al

Diagn Interv Radiol. 2017 , vol 23(2): 106–111

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338575/

■ Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patiens with idiopathic pulmonary fibrosis

Milica Vukmirovic, Jose D. Herazo-Maya, John Blackmon et al

BMC Pulm Med. 2017; 17: 15

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228096/

■ Pulmonary oxygen uptake and muscle deoxygenation kinetics during heavy intensity cycling exercise in patiens with emphysema and idiopathic pulmonary fibrosis

Melitta A. McNarry, Nicholas K. Harrison, Tom Withers et al

BMC Pulm Med. 2017; 17: 26.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282850/

■ Mechanical ventilation in idiopathic pulmonary fibrosis: a nationwide analysis of ventilator use, outcomes, and resource burden

Joshua J. Mooney, Karina Raimundo, Eunice Chang, Michael S. Broder

BMC Pulm Med. 2017; 17: 84

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441011/

■ Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study

Kodai Kawamura, Kazuya Ichikado, Yuko Yasuda et al

BMC Pulm Med. 2017; 17: 94.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477160/

■ Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis